Progesterone receptor membrane component-1 regulates hepcidin biosynthesis
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
Iron homeostasis is tightly regulated by the membrane iron exporter ferroportin and its regulatory peptide hormone hepcidin. The hepcidin/ferroportin axis is considered a promising therapeutic target for the treatment of diseases of iron overload or deficiency. Here, we conducted a chemical screen in zebrafish to identify small molecules that decrease ferroportin protein levels. The chemical screen led to the identification of 3 steroid molecules, epitiostanol, progesterone, and mifepristone, which decrease ferroportin levels by increasing the biosynthesis of hepcidin. These hepcidin-inducing steroids (HISs) did not activate known hepcidin-inducing pathways, including the BMP and JAK/STAT3 pathways. Progesterone receptor membrane component-1 (PGRMC1) was required for HIS-dependent increases in hepcidin biosynthesis, as PGRMC1 depletion in cultured hepatoma cells and zebrafish blocked the ability of HISs to increase hepcidin mRNA levels. Neutralizing antibodies directed against PGRMC1 attenuated the ability of HISs to induce hepcidin gene expression. Inhibiting the kinases of the SRC family, which are downstream of PGRMC1, blocked the ability of HISs to increase hepcidin mRNA levels. Furthermore, HIS treatment increased hepcidin biosynthesis in mice and humans. Together, these data indicate that PGRMC1 regulates hepcidin gene expression through an evolutionarily conserved mechanism. These studies have identified drug candidates and potential therapeutic targets for the treatment of diseases of abnormal iron metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At ovulation, estrogen and testosterone peak, associated with increased iron uptake and erythropoiesis [321].”
From International society of sports nutrition position stand: nutritional concerns of the female athlete (2023) · cites this paper as [321]
Experimental — accuracy not yet measuredIn the citing paper
“In contrast, progesterone, which rises after ovulation and dominates the second half of the cycle (luteal phase) until menstrual bleeding, rather stimulates HAMP expression [75].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
Borgna‐Pignatti, C., Rugolotto, S., Stefano, P. D., Zhao, H., Cappellini, M. D., Vecchio, G. C. D., Romeo, M. A., Forni, G. L., Gamberini, M. R., Ghilardi, R., et al. (2004) · PubMed · Cited by 1,302
Identification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y., Bloch, K. D., & Peterson, R. T. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.2007.54 · Cited by 1,034
Self-citationBone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026
Interleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983
Korchynskyi, O., & ten Dijke, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111023200 · Cited by 881
Research works printed but not linked: 1
- E-mail: peterson@cvrc.mgh.harvard.edu. Or to: Erg11p/Cyp51p in Saccharomyces cerevisiae. Mol Cell Biol. 2005;25(5):1669-1679.
Cited by
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Regulation of the Iron Homeostatic Hormone Hepcidin
Sangkhae, V., & Nemeth, E. (2017) · Advances in Nutrition · doi:10.3945/an.116.013961 · Cited by 443
Liver iron sensing and body iron homeostasis
Wang, C.-Y., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood-2018-06-815894 · Cited by 360
Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors
Levin, E. R., & Hammes, S. R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.122 · Cited by 277
Iron considerations for the athlete: a narrative review
Sim, M., Garvican-Lewis, L. A., Cox, G. R., Govus, A., McKay, A. K. A., Stellingwerff, T., & Peeling, P. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04157-y · Cited by 274
Hepcidin regulation in the anemia of inflammation
Wang, C.-Y., & Babitt, J. L. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000236 · Cited by 250
Lanser, L., Fuchs, D., Kurz, K., & Weiß, G. (2021) · Nutrients · doi:10.3390/nu13113732 · Cited by 211
“Contrary, the female sex hormone progesterone was reported to induce hepcidin production independent of BMP/SMAD signaling [89], while data on estrogen are contradictory [90,91].”
BackgroundNairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
Sebastiani, G., Wilkinson, N., & Pantopoulos, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00160 · Cited by 127
International society of sports nutrition position stand: nutritional concerns of the female athlete
Sims, S. T., Kerksick, C. M., Smith-Ryan, A. E., Janse de Jonge, X. A. K., Hirsch, K. R., Arent, S. M., Hewlings, S. J., Kleiner, S. M., Bustillo, E., Tartar, J. L., et al. (2023) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2023.2204066 · Cited by 129
Hepcidin: A Promising Therapeutic Target for Iron Disorders A Systematic Review
Liu, J. L., Sun, B., Yin, H.-J., & Liu, S. (2016) · Medicine · doi:10.1097/md.0000000000003150 · Cited by 156
“, progesterone and mifepristone) were found to have similar capability to diminish FPN concentration through PGRMC1–SFKs signaling pathway.(56) Ferristatin II, identified as an iron transport inhibitor, induces the internalization and degradation of TfR1, and reduces intestinal iron uptake and serum iron level.”
BackgroundInfluentialPiel, R. B., Shiferaw, M. T., Vashisht, A. A., Marcero, J. R., Praissman, J. L., Phillips, J. D., Wohlschlegel, J. A., & Medlock, A. E. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00756 · Cited by 127
Katsarou, A., & Pantopoulos, K. (2018) · Pharmaceuticals · doi:10.3390/ph11040127 · Cited by 112
“They operate via a pathway involving the progesterone receptor membrane component-1 (PRMC-1) [71].”
BackgroundRyu, C. S., Klein, K., & Zanger, U. M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00159 · Cited by 111
“…metabolism (see below), iron homeostasis and heme trafficking by regulating hepcidin expression and ferrochelatase activity (Craven et al., 2007; Li et al., 2016; Piel et al., 2016), promotion of autophagy through interaction with MAP1LC3B (Mir et al., 2013), regulation of cell cycle,…”
BackgroundThe emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology
Cahill, M. A., Jazayeri, J. A., Catalano, S. M., Toyokuni, S., Kovacevic, Z., & Richardson, D. R. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.07.004 · Cited by 40
“Furthermore, PGRMC1 was found to regulate the induction of the peptide hormone hepcidin (which is an important regulator of iron metabolism by controlling the activity of the membrane iron exporter ferroportin [68]) by a number of steroids, including P4 [69].”
BackgroundHepcidin Signaling in Health and Disease: Ironing Out the Details
Kowdley, K. V., Gochanour, E. M., Sundaram, V., Shah, R. A., & Handa, P. (2021) · Hepatology Communications · doi:10.1002/hep4.1717 · Cited by 123
Bah, A., Pasricha, S., Jallow, M. W., Sise, E. A., Wegmüller, R., Armitage, A. E., Drakesmith, H., Moore, S. E., & Prentice, A. M. (2017) · Journal of Nutrition · doi:10.3945/jn.116.245373 · Cited by 95
“Estrogen and progesterone appear to upregulate hepcidin transcription in cellular and animal models (20), but their role in regulating iron homeostasis in human pregnancy requires further investigation.”
BackgroundBone morphogenic proteins in iron homeostasis
Xiao, X., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · Bone · doi:10.1016/j.bone.2020.115495 · Cited by 94
“Progesterone has been proposed to induce hepcidin via progesterone receptor membrane component-1 and SRC family kinase signaling [117].”
BackgroundIron Homeostasis During Pregnancy: Maternal, Placental, and Fetal Regulatory Mechanisms
Sangkhae, V., Fisher, A. L., Ganz, T., & Nemeth, E. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061021-030404 · Cited by 125
“This increase in hepcidin expression is reported to occur not through the classical nuclear progesterone receptor but through the membrane-bound progesterone receptor PGRMC1 (progesterone receptor membrane component 1) (84).”
BackgroundTherapeutic potential of hepcidin − the master regulator of iron metabolism
Vyoral, D., & Petrák, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.010 · Cited by 85
Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands
Cahill, M. A., & Medlock, A. E. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.12.020 · Cited by 60
“More recently PGRMC1 was shown to regulate hepcidin synthesis and thus 2 regulate iron metabolism central to intermediary metabolism [54].”
BackgroundHepcidin and its therapeutic potential in neurodegenerative disorders
Qian, Z., & Ke, Y. (2019) · Medicinal Research Reviews · doi:10.1002/med.21631 · Cited by 65
Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
Hawula, Z. J., Wallace, D. F., Subramaniam, V. N., & Rishi, G. (2019) · Pharmaceuticals · doi:10.3390/ph12040170 · Cited by 65
The mitochondrial heme metabolon: Insights into the complex(ity) of heme synthesis and distribution
Piel, R. B., Dailey, H. A., & Medlock, A. E. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.01.006 · Cited by 59
Utilizing Zebrafish Visual Behaviors in Drug Screening for Retinal Degeneration
Ganzen, L. C., Venkatraman, P., Pang, C. P., Leung, Y. F., & Zhang, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061185 · Cited by 63
Protective role of estrogen against excessive erythrocytosis in Monge’s disease
Azad, P., Villafuerte, F. C., Bermúdez, D., Patel, G., & Haddad, G. G. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00550-2 · Cited by 59
Iron status in athletic females, a shift in perspective on an old paradigm
Badenhorst, C. E., Goto, K., O’Brien, W. J., & Sims, S. (2021) · Journal of Sports Sciences · doi:10.1080/02640414.2021.1885782 · Cited by 44
“Following ovulation, increases in progesterone may increase hepcidin expression, thus limiting iron utilization (Li et al., 2015) (Figure 2).”
BackgroundInfluentialIron homeostasis: transport, metabolism, and regulation
Guo, S., Frazer, D. M., & Anderson, G. J. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000285 · Cited by 59
Czaja, A. J. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15173 · Cited by 55
“and mifepristone) have been identified in zebrafish that increase hepcidin production outside the BMP and STAT3 pathways (Table 3).(278,291) These steroid molecules require progesterone receptor membrane component‐1 (PRMC‐1) to stimulate hepcidin production.”
BackgroundHepcidin and interleukin‐6 responses to endurance exercise over the menstrual cycle
Barba‐Moreno, L., Alfaro-Magallanes, V. M., de Jonge, X. J., Díaz, Á. E., Cupeiro, R., & Peinado, A. B. (2020) · European Journal of Sport Science · doi:10.1080/17461391.2020.1853816 · Cited by 50
“In addition, some authors (Li et al., 2016) recently found that progesterone presence in animals could lead to an increase in hepcidin expression.”
BackgroundWang, D., Lü, R., Rempała, G. A., & Sadée, W. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.116897 · Cited by 43
“PGRMC1 is known to bind directly to P450 proteins including CYP3A4 and to modulate P450 activity (Oda et al., 2011), with multiple functions in substrate binding, steroid signaling, and more (Rohe et al., 2009; Li et al., 2016); however, its role in P450 expression had not been reported.”
Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease
Małyszko, J., Małyszko, J. S., & Matuszkiewicz‐Rowińska, J. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1599358 · Cited by 43
“On the other hand, progesterone receptor membrane component 1 (PGRMC1), a membrane-bound progesterone receptor also regulates hepcidin synthesis via Src-family tyrosine kinases [SFKs] [38].”
BackgroundMcGuire, M. R., Mukhopadhyay, D., Myers, S. L., Mosher, E. P., Brookheart, R. T., Kammers, K., Sehgal, A., Alpergin, E. S. S., Wolfgang, M. J., Bumpus, N. N., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101316 · Cited by 44
Yadav, P. K., & Singh, A. K. (2022) · Plasmatology · doi:10.1177/26348535221103560 · Cited by 55
“receptor-1), also contributes to the modulation of hepcidin by Src-family tyrosine kinases (SFKs).(46) The downstream signaling of SFKs responsible for the regulation of Hamp expression is still unclear,(46) and needs further study.”
BackgroundPeinado, A. B., Alfaro-Magallanes, V. M., Romero‐Parra, N., Barba‐Moreno, L., Rael, B., Maestre-Cascales, C., Rojo‐Tirado, M. Á., de Castro, E. A., Benito, P. J., Ortega-Santos, C. P., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18020735 · Cited by 46
In Silico Prediction of Steroids and Triterpenoids as Potential Regulators of Lipid Metabolism
Dembitsky, V. M. (2021) · Marine Drugs · doi:10.3390/md19110650 · Cited by 39
A contemporary understanding of iron metabolism in active premenopausal females
Badenhorst, C. E., Forsyth, A. K., & Govus, A. D. (2022) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2022.903937 · Cited by 46
“In vivo results in females undergoing IVF who received daily intramuscular injections of 50mg of P4 had 3-fold and 2-fold higher hepcidin levels on days 6 and 15 of P4 treatments respectively (Li et al., 2015).”
BackgroundInfluentialSulfated and Sulfur-Containing Steroids and Their Pharmacological Profile
Pounina, T. A., Gloriozova, T. A., Savidov, N. A., & Dembitsky, V. M. (2021) · Marine Drugs · doi:10.3390/md19050240 · Cited by 36
Flores-Quijano, M. E., Montalvo-Velarde, I., Vital-Reyes, V. S., Rodríguez‐Cruz, M., Rendón-Macías, M. E., & López‐Alarcón, M. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.11.011 · Cited by 29
Flores-Quijano, M. E., Vega‐Sánchez, R., Tolentino‐Dolores, M. C., López‐Alarcón, M., Flores-Urrutia, M. C., López-Olvera, A. D., & Talavera, J. O. (2019) · Nutrients · doi:10.3390/nu11030693 · Cited by 31
“It has also been proposed that other mechanisms mediated by hormones such as estrogens [41] and progesterone [42] could modify the expression of hepcidin and its action on ferroportin.”
BackgroundLiang, J. L., Yang, C., Liu, T., Tang, P., Huang, H., Wei, H., Liao, Q., Long, J., Zeng, X., Liu, S., et al. (2021) · Environmental Research · doi:10.1016/j.envres.2021.112625 · Cited by 26
Wang, C., Fang, Z., Zhu, Z., Liu, J., & Chen, H. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.05.002 · Cited by 30
Rana, S., & Prabhakar, N. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.10.032 · Cited by 26
PGRMC1 Inhibits Progesterone-Evoked Proliferation and Ca2+ Entry Via STIM2 in MDA-MB-231 Cells
Cantonero, C., Salido, G. M., Rosado, J. A., & Redondo, P. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207641 · Cited by 22
“Furthermore, it has been described that activation of PGRMC1 leads to the activation of certain protein kinases like PKA, PI3K, and SFK [16].”
BackgroundCross, J., Prentice, A. M., & Cerami, C. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa104 · Cited by 23
“Factors that are thought to contribute to maternal hepcidin suppression in the second and third trimesters include maternal iron deficiency, erythropoiesis in the mother or fetus (25), estrogen (26), and progesterone receptor membrane component-1 (27).”
BackgroundAlfaro-Magallanes, V. M., Barba‐Moreno, L., Romero‐Parra, N., Rael, B., Benito, P. J., Swinkels, D. W., Laarakkers, C. M., Díaz, Á. E., Peinado, A. B., & the IronFEMME Study Group (2022) · European Journal of Applied Physiology · doi:10.1007/s00421-022-05048-5 · Cited by 30
“In addition, sex hormones may also have played a role, as progesterone and estrogen have been shown to be able to modulate hepcidin independently of the BMP-SMAD signaling pathway in animal studies (Hou et al. 2012; Yang et al. 2012; Li et al. 2015).”
BackgroundFunction and structural regulation of the carbon monoxide (CO)-responsive membrane protein PGRMC1
Kabe, Y., Handa, H., & Suematsu, M. (2018) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-132 · Cited by 22
Systemic iron homeostasis in female athletes: hepcidin, exercise and sex influence
Barba‐Moreno, L., Alfaro-Magallanes, V. M., Calderón, F. J., & Peinado, A. (2020) · Archivos de medicina del deporte: revista de la Federación Española de Medicina del Deporte y de la Confederación Iberoamericana de Medicina del Deporte · doi:10.18176/archmeddeporte.0009 · Cited by 18
Distinctive modulation of hepcidin in cancer and its therapeutic relevance
Lin, F., Tuffour, A., Hao, G., Addai, F. P., Huang, A., Zhou, Y., & Zhang, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1141603 · Cited by 20
“According to reports, progesterone increases hepcidin expression via progesterone receptor membrane component-1 (PGRMC1) (48).”
BackgroundPharmacological Activities of Epithio Steroids
Dembitsky, V. M., Gloriozova, T. A., & Poroikov, V. (2017) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2017/36199 · Cited by 17
COVID-19 and Progesterone: Part 1. SARS-CoV-2, Progesterone and its potential clinical use
Shah, S. (2021) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2021.100109 · Cited by 18
Parallel Reaction Monitoring reveals structure-specific ceramide alterations in the zebrafish
Zhang, T., Trauger, S. A., Vidoudez, C., Doane, K. P., Pluimer, B. R., & Peterson, R. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-56466-z · Cited by 17
Self-citationControl of adipogenic commitment by a STAT3-VSTM2A axis
Dow, M. A., Silveira, M. A. D., Poliquin, A., Tribouillard, L., Fournier, É., Trébaol, E., Secco, B., Villot, R., Tremblay, F., Bilodeau, S., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2020 · Cited by 19
Iron status at opposite ends of the menstrual function spectrum
Petkus, D. L., Murray‐Kolb, L. E., Scott, S., Ricker, E. A., & Souza, M. J. D. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.10.016 · Cited by 21
Zebrafish as a Platform for Drug Screening
Zhang, T., & Peterson, R. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812431-4.00051-8 · Cited by 14
Self-citationCrosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers
Lai, W., Chen, J., Wang, T., & Liu, Q. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1223493 · Cited by 12
“In zebrafish model, progesterone promotes the degradation of ferroportin and enhances the transcriptional expression of hepcidin (Li et al., 2016).”
BackgroundLancheros-Buitrago, D. J., Rodríguez-Villamil, P., Gregory, J., Bastos, H. B. A., Camacho, C. A., Caballeros, J. E., Cazales, N., Barros, E., Silva, M. J. D. J., Pimentel, A. M., et al. (2019) · Theriogenology · doi:10.1016/j.theriogenology.2019.11.011 · Cited by 11
Haematological disorders following kidney transplantation
Małyszko, J., Basak, G. W., Batko, K., Capasso, G., Capasso, A., Drozd-Sokolowska, J. E., Krzanowska, K., Kulicki, P., Matuszkiewicz‐Rowińska, J., Soler, M. J., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa219 · Cited by 14
Alfaro-Magallanes, V. M., Barba‐Moreno, L., Rael, B., Romero‐Parra, N., Rojo‐Tirado, M. Á., Benito, P. J., Swinkels, D. W., Laarakkers, C. M., Díaz, Á. E., & Peinado, A. B. (2020) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13894 · Cited by 14
McKay, A. K. A., Sim, M., Moretti, D., Hall, R. C., Stellingwerff, T., Burden, R. J., & Peeling, P. (2022) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2021-0343 · Cited by 15
Glycochenodeoxycholate Affects Iron Homeostasis via Up-Regulating Hepcidin Expression
Wang, L.-J., Zhao, G., Wang, X.-F., Liu, X., Li, Y., Qiu, L.-L., Wang, X., & Ren, F. (2022) · Nutrients · doi:10.3390/nu14153176 · Cited by 14
“Previous studies h ve sh hat steroids are related to iron homeostasi [16].”
BackgroundĆurko‐Cofek, B., Kezele, T. G., & Barac-Latas, V. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.07.022 · Cited by 12
Cardiovascular and hematological responses to a dry dynamic apnea in breath hold divers
Brown, C. V., Patrician, A., Tremblay, J. C., Brewster, L. M., Barak, O. F., Drviš, I., Dujić, G., Dujić, Ž., & Ainslie, P. N. (2024) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00081.2024 · Cited by 10
Wang, L., Chen, Q., Ma, R., Zhang, B., Yang, P., Cao, T., Jiao, S., Chen, H., Lin, C., & Cai, H. (2023) · Toxicology · doi:10.1016/j.tox.2023.153515 · Cited by 9
Physiological effect of iron status on patients with polycystic ovary syndrome in Basrah city
Al-Akabi, D. F., & Hafth, H. A. (2023) · Journal of Medical Biochemistry · doi:10.5937/jomb0-39091a · Cited by 10
“It has been observed that hepcidin decreases in the luteal phase and this decreasing is counteracted by elevated levels of progesterone and interleukins in this phase (15).”
BackgroundSolairaja, S., Ramalingam, S., Dunna, N. R., & Venkatabalasubramanian, S. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666211130145542 · Cited by 9
Hepcidin, ferritin and iron homeostasis in pregnant Spanish Purebred mares
Satué, K., Fazio, E., Cravana, C., & Medica, P. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.05.008 · Cited by 12
A 127 kb truncating deletion of PGRMC1 is a novel cause of X-linked isolated paediatric cataract
Jones, J. L., Corbett, M. A., Yeaman, E. J., Zhao, D., Gécz, J., Gasperini, R., Charlesworth, J., Mackey, D. A., Elder, J. E., Craig, J. E., et al. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00889-8 · Cited by 9
“This included a translation start site blocking morpholino (pgrmc1_MO1; 5′ GCTCGACTGCTTCTTCAGCCATTTC 3′) that has previously been reported to knockdown zebrafish pgrmc1 [26, 27] and an exon 1/intron 1 splice site targeting morpholino (pgrmc1_MO2; 5′ATATTTAAGTTGATACCTG GACCGT 3′).”
BackgroundMethodHuang, D., He, J., Zhang, R., Zhong, S., Lai, S., & Jia, Y. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.024 · Cited by 8
Iron, the Essential Micronutrient: A Comprehensive Review of Regulatory Pathways of Iron Metabolism
Horváth, A., Tamási, K., Pap, R., Jánosa, G., & Pandur, E. (2025) · Nutrients · doi:10.3390/nu18010109 · Cited by 16
“Although PGRMC1 influences the function of several signal transduction pathways, the activation of hepcidin through PGRMC1 seems to rely on the activity of Src Family Kinase (SFK), while remaining independent of the PKA, PKC, or PI3 kinase signaling pathways [103].”
Matta, R. A., AbdElftah, M. E., Essawy, M. G., & Saedii, A. A. F. (2022) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-022-00098-9 · Cited by 11
“0n the other hand, progesterone enhances hipcidin synthesis in experimental animals, cell culture, and among non-pregnant women undergoing in vitro fertilization [12].”
BackgroundChanges of Hepcidin, Ferritin and Iron Levels in Cycling Purebred Spanish Mares
Satué, K., Fazio, E., Fauci, D. L., & Medica, P. (2023) · Animals · doi:10.3390/ani13071229 · Cited by 11
“Perhaps, P4 in addition to other factors could explain the higher Hepc levels during the early and late luteal phase, such as reported during the menstrual cycle in women [17].”
BackgroundSigma Receptors: Novel Regulators of Iron/Heme Homeostasis and Ferroptosis
Nguyen, N. T. H., Jaramillo‐Martinez, V., Mathew, M., Suresh, V. V., Sivaprakasam, S., Bhutia, Y. D., & Ganapathy, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914672 · Cited by 12
“These findings highlight the possibility that the pharmacological blockade of PGRMC1 could be beneficial as a treatment strategy for cancer.”
BackgroundQuo vadis PGRMC? Grand-Scale Biology in Human Health and Disease
Cahill, M. A. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2711318 · Cited by 9
Brabin, B. J., Tinto, H., & Roberts, S. A. (2019) · Malaria Journal · doi:10.1186/s12936-019-3013-6 · Cited by 9
Nolte, S., Maier, C., Klügel, S., Weyh, C., Hacker, S., Badenhorst, C. E., & Krüger, K. (2025) · Physiological Reports · doi:10.14814/phy2.70522 · Cited by 10
“For instance, some studies have indicated that fluctuations in estrogen and progesterone levels may influence iron metabolism and erythropoietic activity (Hamad et al., 2020; Li et al., 2016).”
Glucocorticoid and progesterone mechanisms in photoreceptor survival
Marquioni‐Ramella, M. D., Cubilla, M. A., Bermúdez, V., Tate, P. S., Marazita, M. C., & Suburo, Á. M. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107854 · Cited by 7
Yu, K., Li, J., Tian, T., Shi, R., Deng, Y., & Chang, L. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1680625 · Cited by 8
“On one hand, research indicates that progesterone may upregulate the expression of hepcidin, thereby indirectly interfering with the stability of the iron export protein FPN1 and promoting intracellular iron accumulation, which lays the groundwork for ferroptosis activation (Li et al., 2016).”
Natalucci, V., Spinello, G., Moro, T., Pavei, G., Boccia, G., Torre, A. L., & Bonato, M. (2026) · Nutrients · doi:10.3390/nu18071144 · Cited by 7
“This effect may be amplified by premenstrual low-grade inflammation, thereby contributing to functional iron deficiency [113].”
Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity
Barata, I. S., Rueff, J., Kranendonk, M., & Esteves, F. (2024) · Journal of Xenobiotics · doi:10.3390/jox14020034 · Cited by 8
“…enzyme for heme biosynthesis, ferrochelatase, thus controlling heme release [131], (ii) upregulating hepcidin expression, a peptide hormone produced by hepatocytes that plays a role in iron homeostasis [231], and (iii) being able to donate heme to apo-cytochrome b 5 (demonstrated in vitro) [131].”
BackgroundAdaptive Response of Estrogen-Iron Axis in Pregnant Purebred Spanish Mares of Different Age
Satué, K., Fazio, E., Fauci, D. L., Bruschetta, G., & Medica, P. (2023) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2023.104827 · Cited by 4
Sabbir, M. G., Taylor, C. G., & Zahradka, P. C. (2020) · doi:10.21203/rs.3.rs-55518/v1 · Cited by 5
Xu, R., Wang, X. L., Zhang, J., Ren, Y., Su, L., Sang, L., & Su, J. (2026) · Journal of International Medical Research · doi:10.1177/03000605261417447 · Cited by 3
“26,27 From 2004 Q1 to 2024 Q3, frequently reported AEs primarily involved injury, poisoning, general and site-related disorders, and gastrointestinal problems.”
Thicker Than Water: A Social and Evolutionary Study of Iron Deficiency in Women
Miller, E. M. (2023) · doi:10.1093/oso/9780197665718.001.0001 · Cited by 3
Eisenga, M. F., Dullaart, R. P. F., Berger, S. P., Touw, D. J., Bakker, S. J. L., & Gaillard, S. (2017) · American Journal of Hematology · doi:10.1002/ajh.24785 · Cited by 3
“[3] Vasylyev A, Loginov A, Molostvova V, et al.”
Hepcidin: A multifaceted hormone in iron homeostasis and tumor biology
Liu, X., Zhang, X., Fan, Y., & Tan, K. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.10.003 · Cited by 3
Iron biomarkers predict peripheral artery disease in females
Agarvas, A. R., Kopf, S., Lopes, T. J. S., Atkins, J. L., Thalmann, P., Fernández‐Real, J. M., Nawroth, P. P., & Muckenthaler, M. U. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119111 · Cited by 4
HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030683 · Cited by 3
“On the contrary, progesterone induces hepcidin production independent of the BMP/SMAD pathway [171].”
Iron Status in Sport Horses: Is It Important for Equine Athletes?
Kiełbik, P., & Witkowska‐Piłaszewicz, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125653 · Cited by 5
Alfaro-Magallanes, V. M., Moreno, L. B., & Peinado, A. (2021) · Archivos de medicina del deporte: revista de la Federación Española de Medicina del Deporte y de la Confederación Iberoamericana de Medicina del Deporte · doi:10.18176/archmeddeporte.00022 · Cited by 4
“…2013; Roecker et al. 2005; Sim et al. 2014; Peeling et al. 2008; Peeling et al. 2009; McClung 2012; Goldstein 2016; Pedersen and Febbraio 2008; Constantini, Dubnov, and Lebrun 2005; Lehtihet et al. 2016; Yang et al. 2012; Hou et al. 2012; Qian et al. 2015; Li et al. 2016; Bajbouj et al. 2018).”
BackgroundAnand, R., Sparla, R., Atkins, J. L., Altamura, C., Anderson, T. J., Aşıcıoğlu, E., Bassols, J., López‐Bermejo, A., Dvořáková, H. M., Fernández‐Real, J. M., et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05796-8 · Cited by 3
“While the influence of female sexual hormones on iron homeostasis is known [9, 10], previous studies have not found consistent evidence linking factors such as parity, timing of menopause, duration of the reproductive period, use of hormone therapy or contraceptives with CC-IMT [71, 72].”
Metabolism of Iron Ions and Its Role in Regulating the Functions of Immune System Cells
Orlova, E. G., & Gorbunova, O. L. (2026) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093026020018 · Cited by 2
Commentaries on Viewpoint: Consider iron status when making sex comparisons in human physiology
Badenhorst, C. E., Millet, G. P., Debevec, T., Brocherie, F., Coates, A. M., Burr, J. F., Andersen, A. B., Bejder, J., Gliemann, L., Pedlar, C. R., et al. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00016.2022 · Cited by 1
Moreno, L. B. (2018) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.53244 · Cited by 1
ADAR1 Regulates Lipid Remodeling to Dictate Ferroptosis SensitivityPreprint
Kung, C.-P., Terzich, N., Ilagan, M. X. G., Prinsen, M. J., Kaushal, M., Kladney, R. D., Weber, J., Mabry, A., Torres, L. S., Bramel, E. R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633410 · Cited by 1
Identification and analysis of genetic and chemical modulators of iron metabolism
Hawula, Z. J. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.225904 · Cited by 1
Alfaro-Magallanes, V. M. (2022) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.71841
Association between tumor markers and anemia: a short review
Soltani, N., Moghimian‐Boroujeni, B., Abdolalian, M., & Javan, M. R. (2023) · Acta Haematologica Polonica · doi:10.5603/ahp.a2023.0014
“Progesterone receptor membrane component 1 (PGRMC1) Progesterone-PGRMC1 complex can reduce iron levels by increasing hepcidin expression [36, 37]”
BackgroundInfluentialHer Flesh and Blood: Iron and Women’s Reproduction
Miller, E. M. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197665718.003.0003
Metadata
- Authors
- Li, X., Rhee, D. K., Malhotra, R., Mayeur, C., Hurst, L. A., Ager, E., Shelton, G., Kramer, Y., McCulloh, D., Keefe, D., Bloch, K. D., Bloch, D. B., & Peterson, R. T.
- Affiliations
- Broad Institute (US)
- Cardiovascular Research Center (BR)
- Harvard University (US)
- NYU Langone Health (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2015-12-14
- Volume
- 126
- Issue
- 1
- Pages
- 389-401
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701562
- OpenAlex
- W2201070551
- Cited by
- 112
- References
- 68
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 3 · 2023: 23 · 2022: 9 · 2021: 15 · 2020: 9 · 2019: 13 · 2018: 5 · 2017: 10 · 2016: 10
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Fondation Leducq (T32HL007208)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (K08HL111210, T32HL007208)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK082971)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- PGRMC1, ferroportin, iron homeostasis, steroid hormones, progesterone, mifepristone, Src family kinases, iron overload, iron deficiency, drug candidates
- MeSH terms
- Ferroportin, Androstanols, Animals, Female, Gene Expression Regulation, Humans, Membrane Proteins, Progesterone, Receptors, Progesterone, Zebrafish, Signal Transduction, Mifepristone, Bone Morphogenetic Proteins, Cation Transport Proteins, STAT3 Transcription Factor, Mice, Hep G2 Cells, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.